Auxier Asset Management boosted its stake in Aetna Inc (NYSE:AET) by 27.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,743 shares of the company’s stock after buying an additional 1,435 shares during the quarter. Auxier Asset Management’s holdings in Aetna were worth $1,237,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Cornerstone Advisors Inc. lifted its stake in Aetna by 263.6% in the 1st quarter. Cornerstone Advisors Inc. now owns 600 shares of the company’s stock worth $101,000 after purchasing an additional 435 shares in the last quarter. Bruderman Asset Management LLC purchased a new position in Aetna in the 1st quarter worth approximately $118,000. Kaizen Advisory LLC lifted its stake in Aetna by 143.9% in the 2nd quarter. Kaizen Advisory LLC now owns 766 shares of the company’s stock worth $141,000 after purchasing an additional 452 shares in the last quarter. Clearwater Capital Advisors LLC purchased a new position in Aetna in the 1st quarter worth approximately $154,000. Finally, CSat Investment Advisory L.P. purchased a new position in Aetna in the 2nd quarter worth approximately $162,000. 83.51% of the stock is currently owned by institutional investors and hedge funds.
Shares of NYSE AET opened at $203.03 on Friday. The company has a market cap of $66.20 billion, a PE ratio of 20.59, a PEG ratio of 1.73 and a beta of 0.68. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.74 and a quick ratio of 0.74. Aetna Inc has a 1 year low of $149.69 and a 1 year high of $204.20.
Aetna (NYSE:AET) last posted its earnings results on Thursday, August 2nd. The company reported $3.43 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.04 by $0.39. Aetna had a net margin of 5.77% and a return on equity of 20.66%. The firm had revenue of $15.56 billion during the quarter, compared to the consensus estimate of $15.59 billion. During the same quarter last year, the firm earned $3.42 EPS. The firm’s revenue for the quarter was up .2% on a year-over-year basis. sell-side analysts expect that Aetna Inc will post 11.31 EPS for the current fiscal year.
A number of brokerages have recently issued reports on AET. Cantor Fitzgerald downgraded shares of Aetna from an “overweight” rating to a “neutral” rating and set a $202.00 price target for the company. in a report on Wednesday, August 22nd. Zacks Investment Research upgraded shares of Aetna from a “sell” rating to a “hold” rating in a report on Monday, August 6th. Finally, ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a report on Tuesday, June 26th. Eight analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Aetna currently has a consensus rating of “Hold” and an average target price of $200.38.
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Recommended Story: Book Value Per Share – BVPS
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.